Hence, further studies may allow us to shed further light in the design of other species with enhanced activities aimed to develop new, specific, yet safer antineoplastic agents, related to the breast cancer estrogen receptors (ERα and GPER). This evidence concerns the gene ESR1 and breast cancer.